Solid-phase modular synthesis of park nucleotide and lipids I and II analogues was written by Katsuyama, Akira;Sato, Kousuke;Yakushiji, Fumika;Matsumaru, Takanori;Ichikawa, Satoshi. And the article was included in Chemical & Pharmaceutical Bulletin in 2018.SDS of cas: 156311-83-0 The following contents are mentioned in the article:
A solid-phase synthesis of Park nucleotide as well as lipids I and II analogs, which is applicable to the synthesis of a range of analogs, is described in this work. This technique allows highly functionalized macromols. to he modularly labeled. Multiple steps are used in a short time (4d) with a single purification step to synthesize the mols. by solid-phase synthesis. This study involved multiple reactions and reactants, such as ((3H-[1,2,3]Triazolo[4,5-b]pyridin-3-yl)oxy)tri(pyrrolidin-1-yl)phosphonium hexafluorophosphate(V) (cas: 156311-83-0SDS of cas: 156311-83-0).
((3H-[1,2,3]Triazolo[4,5-b]pyridin-3-yl)oxy)tri(pyrrolidin-1-yl)phosphonium hexafluorophosphate(V) (cas: 156311-83-0) belongs to triazole derivatives. The many free lone pairs in triazoles make them useful as coordination compounds, although not typically as haptic ligands. Many triazoles have antifungal effects: the triazole antifungal drugs include fluconazole, isavuconazole, itraconazole, voriconazole, pramiconazole, ravuconazole, and posaconazole and triazole plant-protection fungicides include epoxiconazole, triadimenol, myclobutanil, propiconazole, prothioconazole, metconazole, cyproconazole, tebuconazole, flusilazole and paclobutrazol.SDS of cas: 156311-83-0
Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics